Authors:
YASUI N
KONDO T
OTANI K
FURUKORI H
KANEKO S
OHKUBO T
NAGASAKI T
SUGAWARA K
Citation: N. Yasui et al., EFFECT OF ITRACONAZOLE ON THE SINGLE ORAL DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF ALPRAZOLAM, Psychopharmacology, 139(3), 1998, pp. 269-273
Authors:
SUZUKI A
OTANI K
MIHARA K
YASUI N
KONDO T
TOKINAGA N
FURUKORI H
KANEKO S
INOUE Y
HAYASHI K
Citation: A. Suzuki et al., EFFECTS OF VARIOUS FACTORS INCLUDING THE CYP2D6 GENOTYPE AND COADMINISTRATION OF FLUNITRAZEPAM ON THE STEADY-STATE PLASMA-CONCENTRATIONS OFBROMPERIDOL AND ITS REDUCED METABOLITE, Psychopharmacology, 135(4), 1998, pp. 333-337
Authors:
FURUKORI H
OTANI K
YASUI N
KONDO T
KANEKO S
SHIMOYAMA R
OHKUBO T
NAGASAKI T
SUGAWARA K
Citation: H. Furukori et al., EFFECT OF CARBAMAZEPINE ON THE SINGLE ORAL DOSE PHARMACOKINETICS OF ALPRAZOLAM, Neuropsychopharmacology, 18(5), 1998, pp. 364-369
Authors:
YASUI N
OTANI K
KONDO T
SUZUKI A
FURUKORI H
KANEKO S
INOUE Y
Citation: N. Yasui et al., CORRELATION BETWEEN STEADY-STATE PLASMA-CONCENTRATIONS (CSS) OF BROMPERIDOL AND HALOPERIDOL, Progress in neuro-psychopharmacology & biological psychiatry, 22(3), 1998, pp. 485-492
Authors:
OTANI K
KONDO T
YASUI N
SUZUKI A
FURUKORI H
KANEKO S
OHKUBO T
NAGASAKI T
SUGAWARA K
HAYASHI K
Citation: K. Otani et al., PROLACTIN RESPONSE TO NEMONAPRIDE, A NEW ANTIPSYCHOTIC DRUG, IN SCHIZOPHRENIC-PATIENTS, Human psychopharmacology, 12(6), 1997, pp. 591-594
Authors:
OTANI K
YASUI N
FURUKORI H
KANEKO S
TASAKI H
OHKUBO T
NAGASAKI T
SUGAWARA K
HAYASHI K
Citation: K. Otani et al., RELATIONSHIP BETWEEN SINGLE ORAL DOSE PHARMACOKINETICS OF ALPRAZOLAM AND TRIAZOLAM, International clinical psychopharmacology, 12(3), 1997, pp. 153-157